Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
This grant funds exploratory clinical trials focused on arthritis and musculoskeletal and skin diseases.
About this program
The Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) are designed to support innovative clinical trials that aim to advance the understanding and treatment of arthritis and related conditions. This grant is intended for researchers and institutions that are conducting early-stage clinical trials to explore new therapeutic approaches. The funding will facilitate the development of novel interventions and improve patient outcomes in these areas of health.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and other research entities conducting clinical trials in the specified fields.
Requirements
- Clinical trial must be exploratory in nature
- Research must focus on arthritis and musculoskeletal and skin diseases